Sigilon Therapeutics' Partnership

Sigilon Therapeutics raised a round of funding on April 04, 2018. Investors include Eli Lilly & Co..

Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromer …

Articles about Sigilon Therapeutics' Partnership: